Operating Income for Bristol-Myers Squibb (BMY)
According to Bristol-Myers Squibb's latest reported financial statements, the company's current operating income (TTM) is $12.70B USD. Operating income is profit from core operations: revenue minus cost of goods sold and operating expenses (SG&A, R&D). It excludes interest, taxes, and non-operating items, so it isolates how profitable the business itself is before financing and tax decisions. Compare with EBITDA and net income.
Headline TTM above sums the four reported quarters through (reported ). Chart and table below cover the full reported history back to .
Currently viewingOperating IncomeSwitch metric
TTM (last 4 quarters)
$12.70B
YoY change
+31.5%
5Y CAGR
+23.1%
Peak year (2025)
$12.70B
Cumulative operating income
$188.83B
Operating Income history chart for Bristol-Myers Squibb (BMY) from 1987 to 2025
Operating Income history table for Bristol-Myers Squibb (BMY) from 1987 to 2025
| Fiscal year | Period ended | Reported | Operating Income | YoY |
|---|---|---|---|---|
| 2025 | $12.70B | +31.5% | ||
| 2024 | $9.66B | +14.0% | ||
| 2023 | $8.47B | -8.6% | ||
| 2022 | $9.27B | -2.8% | ||
| 2021 | $9.54B | +112.4% | ||
| 2020 | $4.49B | -30.2% | ||
| 2019 | $6.44B | +0.7% | ||
| 2018 | $6.39B | +22.0% | ||
| 2017 | $5.24B | +1.2% | ||
| 2016 | $5.18B | +31.5% | ||
| 2015 | $3.94B | +25.6% | ||
| 2014 | $3.13B | +0.2% | ||
| 2013 | $3.13B | -26.6% | ||
| 2012 | $4.27B | -36.8% | ||
| 2011 | $6.75B | +10.0% | ||
| 2010 | $6.14B | +21.6% | ||
| 2009 | $5.05B | +3.5% | ||
| 2008 | $4.88B | +29.4% | ||
| 2007 | $3.77B | +42.6% | ||
| 2006 | $2.64B | -36.0% | ||
| 2005 | $4.13B | -12.2% | ||
| 2004 | $4.70B | -4.7% | ||
| 2003 | $4.93B | +20.3% | ||
| 2002 | $4.10B | -20.5% | ||
| 2001 | $5.16B | -13.8% | ||
| 2000 | $5.99B | +14.3% | ||
| 1999 | $5.24B | +17.6% | ||
| 1998 | $4.46B | +0.4% | ||
| 1997 | $4.44B | +12.3% | ||
| 1996 | $3.95B | +9.3% | ||
| 1995 | $3.62B | +12.2% | ||
| 1994 | $3.22B | +34.0% | ||
| 1993 | $2.40B | +22.6% | ||
| 1992 | $1.96B | -29.1% | ||
| 1991 | $2.77B | +15.8% | ||
| 1990 | $2.39B | +120.6% | ||
| 1989 | $1.08B | -38.8% | ||
| 1988 | $1.77B | +20.7% | ||
| 1987 | $1.47B | — |
Operating Income values are taken from Bristol-Myers Squibb's reported income statements (10-Q quarterly and 10-K annual filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the date the filing was reported; YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
Analysis
As of the 2025 fiscal year, Bristol-Myers Squibb (BMY) reported operating income of $12.70B – surged 31.5% year-over-year.
Across 2020–2025 (5 years), Bristol-Myers Squibb operating income produced a CAGR of +23.1% – sustaining 2 straight years of year-over-year growth.
The highest annual operating income of $12.70B was reported in 2025. The lowest in the available history was $1.08B in 1989.
Within Healthcare, Bristol-Myers Squibb (BMY) ranks 8th among 8 peers we track. The peer median for operating income is $22.84B.
Bristol-Myers Squibb Operating Income by Year
Bristol-Myers Squibb Operating Income 2025: $12.70B
Bristol-Myers Squibb operating income in 2025 was $12.70B, surged 31.5% from 2024. This figure represents the highest annual value in the available history.
Bristol-Myers Squibb Operating Income 2024: $9.66B
Bristol-Myers Squibb operating income in 2024 was $9.66B, grew 14.0% from 2023.
Bristol-Myers Squibb Operating Income 2023: $8.47B
Bristol-Myers Squibb operating income in 2023 was $8.47B, declined 8.6% below 2022.
Bristol-Myers Squibb Operating Income 2022: $9.27B
Bristol-Myers Squibb operating income in 2022 was $9.27B, edged down 2.8% below 2021.
Bristol-Myers Squibb Operating Income 2021: $9.54B
Bristol-Myers Squibb operating income in 2021 was $9.54B.
See more financial history for Bristol-Myers Squibb (BMY).
Sector peers — Operating Income
Companies in the same sector as Bristol-Myers Squibb, ranked by their latest operating income.
| Company | Operating Income | Sector |
|---|---|---|
| Novo Nordisk A/S (NVO) | $127.66B | Healthcare |
| Eli Lilly and Company (LLY) | $29.70B | Healthcare |
| Merck & Co., Inc. (MRK) | $26.78B | Healthcare |
| Johnson & Johnson (JNJ) | $25.60B | Healthcare |
| AbbVie Inc. (ABBV) | $20.09B | Healthcare |
| UnitedHealth Group Incorporated (UNH) | $18.96B | Healthcare |
| AstraZeneca PLC (AZN) | $13.74B | Healthcare |
| Amgen Inc. (AMGN) | $10.68B | Healthcare |
Frequently asked questions
What is Bristol-Myers Squibb's operating income?
- Latest reported operating income for Bristol-Myers Squibb (BMY) is $12.70B (period ending December 31, 2025).
How has Bristol-Myers Squibb operating income changed year-over-year?
- Bristol-Myers Squibb (BMY) operating income changed +31.5% year-over-year on the latest annual filing.
What is the long-term growth rate of Bristol-Myers Squibb operating income?
- Bristol-Myers Squibb (BMY) operating income compound annual growth rate is +23.1% over the most recent 5 years available.
When did Bristol-Myers Squibb operating income hit its highest annual value?
- Bristol-Myers Squibb operating income reached its highest annual value of $12.70B in 2025.
What was Bristol-Myers Squibb operating income in 2024?
- Bristol-Myers Squibb (BMY) operating income in 2024 was $9.66B.
What was Bristol-Myers Squibb operating income in 2025?
- Bristol-Myers Squibb (BMY) operating income in 2025 was $12.70B.
Metrics overview
Pick a metric for charts, filings, and peers — each row shows the latest TTM or annual value with year-over-year change.
Explore more
BMY Overview
Company profile, financial tools, and key metrics
BMY Revenue Counter
Earns $1,528 every second. See per minute, hour, and day.
BMY Earnings Counter
Earns $223.65 per second net profit. See per minute, hour, and day.
BMY Economic Scale
Exceeds Bahrain's GDP. Compare with world economies.
BMY What If Invested
What if you had invested $1,000? See historical returns from any date.
BMY How It Makes Money
Discover visual breakdown of $48.19B in revenue — where it comes from and where it goes.
BMY Stock Seasonality
Best and worst months to invest. Historical monthly returns heatmap.
BMY Price Target Scenarios
Model bear, base, and bull cases with EPS growth and exit P/E — pre-filled from analysts and history.
BMY Daily Price Character
Steady · 47.3% historical win rate (green days). Streaks & record days.
BMY Buybacks
Recent repurchase activity. Shareholder yield & SBC comparison.
BMY Stock Split History
6 splits on record. Dates, ratios, and cumulative multiple.
BMY Dividend Profile
Yield: 4.34%. Safety: 7/8. See full history.
BMY Dividend Calculator
How much dividend income would $1,000 have earned? Calculate from any date.
BMY Dividend Forecast
Project future income with DRIP, growth assumptions, and optional monthly contributions.